These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 20145256)
1. Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression. Cornu M; Modi H; Kawamori D; Kulkarni RN; Joffraud M; Thorens B J Biol Chem; 2010 Apr; 285(14):10538-45. PubMed ID: 20145256 [TBL] [Abstract][Full Text] [Related]
2. GLP-1 protects β-cells against apoptosis by enhancing the activity of an IGF-2/IGF1-receptor autocrine loop. Cornu M; Thorens B Islets; 2009; 1(3):280-2. PubMed ID: 21099285 [TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop. Cornu M; Yang JY; Jaccard E; Poussin C; Widmann C; Thorens B Diabetes; 2009 Aug; 58(8):1816-25. PubMed ID: 19401425 [TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP. Hou Y; Ernst SA; Heidenreich K; Williams JA Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397 [TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 cleavage product GLP-1(9-36) reduces neuroinflammation from stroke via the activation of insulin-like growth factor 1 receptor in astrocytes. Huang J; Liu Y; Cheng L; Li J; Zhang T; Zhao G; Zhang H Eur J Pharmacol; 2020 Nov; 887():173581. PubMed ID: 32949596 [TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells. Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020 [TBL] [Abstract][Full Text] [Related]
8. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor. Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940 [TBL] [Abstract][Full Text] [Related]
9. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion. Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122 [TBL] [Abstract][Full Text] [Related]
11. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells. Lee YS; Jun HS Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094 [TBL] [Abstract][Full Text] [Related]
12. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis. Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816 [TBL] [Abstract][Full Text] [Related]
13. Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells. Shang J; Li J; Keller MP; Hohmeier HE; Wang Y; Feng Y; Zhou HH; Shen X; Rabaglia M; Soni M; Attie AD; Newgard CB; Thornberry NA; Howard AD; Zhou YP Mol Endocrinol; 2015 Sep; 29(9):1243-53. PubMed ID: 26218441 [TBL] [Abstract][Full Text] [Related]
14. Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling. Yang L; Yao D; Yang H; Wei Y; Peng Y; Ding Y; Shu L Mol Endocrinol; 2016 Mar; 30(3):361-71. PubMed ID: 26789107 [TBL] [Abstract][Full Text] [Related]
15. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells. Quoyer J; Longuet C; Broca C; Linck N; Costes S; Varin E; Bockaert J; Bertrand G; Dalle S J Biol Chem; 2010 Jan; 285(3):1989-2002. PubMed ID: 19915011 [TBL] [Abstract][Full Text] [Related]
16. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents. Arakawa M; Ebato C; Mita T; Hirose T; Kawamori R; Fujitani Y; Watada H Biochem Biophys Res Commun; 2009 Dec; 390(3):809-14. PubMed ID: 19836346 [TBL] [Abstract][Full Text] [Related]
17. Requirement for the intestinal epithelial insulin-like growth factor-1 receptor in the intestinal responses to glucagon-like peptide-2 and dietary fat. Markovic MA; Srikrishnaraj A; Tsang D; Brubaker PL FASEB J; 2020 May; 34(5):6628-6640. PubMed ID: 32212202 [TBL] [Abstract][Full Text] [Related]
18. Glutamine stimulates biosynthesis and secretion of insulin-like growth factor 2 (IGF2), an autocrine regulator of beta cell mass and function. Modi H; Cornu M; Thorens B J Biol Chem; 2014 Nov; 289(46):31972-31982. PubMed ID: 25271169 [TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line. Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124 [TBL] [Abstract][Full Text] [Related]
20. Insulin and IGF-1 receptor autocrine loops are not required for Exendin-4 induced changes to pancreatic β-cell bioenergetic parameters and metabolism in BRIN-BD11 cells. Rowlands J; Cruzat V; Carlessi R; Newsholme P Peptides; 2018 Feb; 100():140-149. PubMed ID: 29412813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]